Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 1 6Phase 1/2 4Phase NA 3Phase EARLY_PHASE1 2Phase 4 2Phase 3 2

Status

Completed 17Terminated 3Withdrawn 2Unknown 2Active not recruiting 2Recruiting 1Enrolling by invitation 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Lymphoma, Follicular 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Unknown × fludarabine phosphate × Clear all
NCT00006250 2013-09-20

Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
500 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT00017108 2008-07-24

Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡